118 related articles for article (PubMed ID: 32218815)
1. Interferon-β sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02.
Lohmann B; Le Rhun E; Silginer M; Epskamp M; Weller M
Oncol Lett; 2020 Apr; 19(4):2649-2656. PubMed ID: 32218815
[TBL] [Abstract][Full Text] [Related]
2. Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibition.
Le Rhun E; von Achenbach C; Lohmann B; Silginer M; Schneider H; Meetze K; Szabo E; Weller M
Int J Cancer; 2019 Jul; 145(1):242-253. PubMed ID: 30549269
[TBL] [Abstract][Full Text] [Related]
3. The multi-kinase inhibitor TG02 overcomes signalling activation by survival factors to deplete MCL1 and XIAP and induce cell death in primary acute myeloid leukaemia cells.
Pallis M; Abdul-Aziz A; Burrows F; Seedhouse C; Grundy M; Russell N
Br J Haematol; 2012 Oct; 159(2):191-203. PubMed ID: 22934750
[TBL] [Abstract][Full Text] [Related]
4. Targeting of cyclin-dependent kinases in atypical teratoid rhabdoid tumors with multikinase inhibitor TG02.
Ding AS; Huq S; Casaos J; Raj D; Morales M; Zhao T; Kim T; Srivastava S; Pant A; Serra R; Gorelick NL; Brem H; Tyler B
J Neurosurg Pediatr; 2021 Sep; 28(6):734-743. PubMed ID: 34479190
[TBL] [Abstract][Full Text] [Related]
5. Interferon-β induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells.
Happold C; Roth P; Silginer M; Florea AM; Lamszus K; Frei K; Deenen R; Reifenberger G; Weller M
Mol Cancer Ther; 2014 Apr; 13(4):948-61. PubMed ID: 24526161
[TBL] [Abstract][Full Text] [Related]
6. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
[TBL] [Abstract][Full Text] [Related]
7. Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models.
von Achenbach C; Weller M; Kaulich K; Gramatzki D; Zacher A; Fabbro D; Reifenberger G; Szabó E
J Neurochem; 2020 May; 153(4):510-524. PubMed ID: 31618458
[TBL] [Abstract][Full Text] [Related]
8. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02.
von Achenbach C; Le Rhun E; Sahm F; Wang SS; Sievers P; Neidert MC; Rushing EJ; Lawhon T; Schneider H; von Deimling A; Weller M
Transl Oncol; 2020 Dec; 13(12):100852. PubMed ID: 32916418
[TBL] [Abstract][Full Text] [Related]
10. MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.
Yacoub A; Mitchell C; Hong Y; Gopalkrishnan RV; Su ZZ; Gupta P; Sauane M; Lebedeva IV; Curiel DT; Mahasreshti PJ; Rosenfeld MR; Broaddus WC; James CD; Grant S; Fisher PB; Dent P
Cancer Biol Ther; 2004 Aug; 3(8):739-51. PubMed ID: 15197348
[TBL] [Abstract][Full Text] [Related]
11. TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties.
Goh KC; Novotny-Diermayr V; Hart S; Ong LC; Loh YK; Cheong A; Tan YC; Hu C; Jayaraman R; William AD; Sun ET; Dymock BW; Ong KH; Ethirajulu K; Burrows F; Wood JM
Leukemia; 2012 Feb; 26(2):236-43. PubMed ID: 21860433
[TBL] [Abstract][Full Text] [Related]
12. Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity.
Lohmann B; Silginer M; Picard D; Schneider H; Remke M; Roth P; Reifenberger G; Weller M
Neurooncol Adv; 2020; 2(1):vdaa043. PubMed ID: 32642697
[TBL] [Abstract][Full Text] [Related]
13. Induction of growth suppression and modification of gene expression in multi-drug-resistant human glioblastoma multiforme cells by recombinant human fibroblast and immune interferon.
Moulton TA; Jiang H; Guarini L; Fetell MR; Fisher PB
Int J Cancer; 1992 May; 51(3):373-8. PubMed ID: 1317362
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myeloma.
Ponder KG; Matulis SM; Hitosugi S; Gupta VA; Sharp C; Burrows F; Nooka AK; Kaufman JL; Lonial S; Boise LH
Cancer Biol Ther; 2016 Jul; 17(7):769-77. PubMed ID: 27246906
[TBL] [Abstract][Full Text] [Related]
15. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons.
Vita JR; Edwalds GM; Gorey T; Housepian EM; Fetell MR; Guarini L; Langer JA; Fisher PB
Anticancer Res; 1988; 8(3):297-302. PubMed ID: 2839097
[TBL] [Abstract][Full Text] [Related]
16. Synergistic interaction between 17-AAG and phosphatidylinositol 3-kinase inhibition in human malignant glioma cells.
Premkumar DR; Arnold B; Jane EP; Pollack IF
Mol Carcinog; 2006 Jan; 45(1):47-59. PubMed ID: 16267832
[TBL] [Abstract][Full Text] [Related]
17. Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells.
Premkumar DR; Jane EP; Pollack IF
Cancer Biol Ther; 2015; 16(2):233-43. PubMed ID: 25482928
[TBL] [Abstract][Full Text] [Related]
18. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells.
Zhang R; Banik NL; Ray SK
Cancer Chemother Pharmacol; 2008 Aug; 62(3):407-16. PubMed ID: 17960384
[TBL] [Abstract][Full Text] [Related]
19. Caspase-9 pathway activation by inhibiting endogenous fibroblast growth factor signaling in human glioma cells.
Fukushima S; Kato S; Maeda M; Shigemori M
Int J Oncol; 2008 Feb; 32(2):467-73. PubMed ID: 18202770
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21.
Giandomenico V; Vaccari G; Fiorucci G; Percario Z; Vannuchi S; Matarrese P; Malorni W; Romeo G; Affabris GR
Eur Cytokine Netw; 1998 Dec; 9(4):619-31. PubMed ID: 9889406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
